SHADOW ADJUDICATION Trademark

Trademark Overview


On Monday, November 3, 2025, a trademark application was filed for SHADOW ADJUDICATION with the United States Patent and Trademark Office. The USPTO has given the SHADOW ADJUDICATION trademark a serial number of 99476469. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 21, 2026. This trademark is owned by Prime Therapeutics LLC. The SHADOW ADJUDICATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a Service (PAAS) featuring computer software platforms for providing comparisons of data and information from legacy software systems to new software systems to assist in data migration, data integration, business implementations, data configuration, and to identify and resolve issues to minimize post-implementation disruptions in the field of medical clinical trials, medical and prescription drug benefits, utilization and coverage
shadow adjudication

General Information


Serial Number99476469
Word MarkSHADOW ADJUDICATION
Filing DateMonday, November 3, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2026

Trademark Statements


Goods and ServicesPlatform as a Service (PAAS) featuring computer software platforms for providing comparisons of data and information from legacy software systems to new software systems to assist in data migration, data integration, business implementations, data configuration, and to identify and resolve issues to minimize post-implementation disruptions in the field of medical clinical trials, medical and prescription drug benefits, utilization and coverage

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrime Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121
US

Party NamePrime Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121
US

Trademark Events


Event DateEvent Description
Monday, November 3, 2025NEW APPLICATION ENTERED
Monday, November 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 3, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, March 17, 2026ASSIGNED TO EXAMINER
Wednesday, March 18, 2026NON-FINAL ACTION WRITTEN
Wednesday, March 18, 2026NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 25, 2026EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 25, 2026EXAMINERS AMENDMENT E-MAILED
Wednesday, March 25, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 25, 2026EXAMINER'S AMENDMENT ENTERED
Wednesday, March 25, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2026PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED